FABP4, an adipokine that is positively associated with obesity and metabolic syndrome, was demonstrated to positively control the NLRP3 inflammasome through downregulating UCP2 expression in a paracrine manner [90,91]. The gene discussed is NLRP3; the disease is obesity disorder.